Growth Metrics

Apyx Medical (APYX) Return on Equity (2016 - 2026)

Apyx Medical filings provide 15 years of Return on Equity readings, the most recent being 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Apyx Medical, up from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2021 to a low of 0.03% in Q3 2025.
  • Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: decreased -2bps in 2024 and later rose 1bps in 2025.
  • Apyx Medical's Return on Equity stood at 0.0% in 2021, then plummeted by -108bps to 0.01% in 2022, then dropped by -7bps to 0.01% in 2023, then plummeted by -227bps to 0.02% in 2024, then soared by 47bps to 0.01% in 2025.
  • The last three reported values for Return on Equity were 0.01% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.